Cargando…
Challenges in nanomedicine clinical translation
New nanomedicine formulations and novel applications of nanomedicinal drugs are reported on an almost daily basis. While academic progress and societal promise continue to shoot for the stars, industrial acceptance and clinical translation are being looked at increasingly critically. We here discuss...
Autores principales: | Metselaar, Josbert M., Lammers, Twan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228980/ https://www.ncbi.nlm.nih.gov/pubmed/32166632 http://dx.doi.org/10.1007/s13346-020-00740-5 |
Ejemplares similares
-
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018) -
Nanomedicine formulations for combination therapies
por: Lammers, Twan, et al.
Publicado: (2010) -
Cancer nanomedicine
por: Bhatia, Sangeeta N., et al.
Publicado: (2022) -
Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies
por: Man, Francis, et al.
Publicado: (2018) -
Cancer nanomedicine meets immunotherapy: opportunities and challenges
por: Sun, Qingxue, et al.
Publicado: (2020)